… of glioblastoma treatment response will benefit patients and … that act as biomarkers of
treatment effectiveness are required. … An ADC map was calculated for each patient with a b-value …

… treatment, “monitoring biomarkers” are measured serially and are required to detect any change
in the extent of glioma infiltration or provide evidence of treatment response (… rCBV maps …

… BRAIN-RANO response criteria for high-grade gliomas [29]. … asymmetry maps at 1.5T are
visually distinct between patients… seen over the course of therapy. In Supplementary Fig. S5, it …

… hence, represents a surrogate of treatment resistance. This hypothesis is … maps in patients
with Grade 3 and 4 gliomas before and midway through radiotherapy, and found that patients …

… from treatment effect following therapy for malignant gliomas … therapies or to premature
termination of effective therapies. … using the determined B 0 map from the water saturation shift-…

… in malignant gliomas and improve patient outcome [45]. … in order to provide metabolic maps
to neurosurgeons and … prognostication of patient outcome and glioma treatment response. …

… We interrogated the TCGA glioma database, mapping these and other mutations against
expressions of pyrimidine synthetic enzymes and the KEGG pyrimidine metabolism signature. …

… response and assess treatment effect on whole brain. This study highlights the potential of
belinostat to be a synergistic therapeutic agent in the treatment of gliomas. … metabolite maps …

… Furthermore, we analyzed apparent diffusion coefficient (ADC) maps derived from …
treatment response to REG was poor in our cohort of patients with late-stage malignant gliomas…

… treatment effect from tumor in recurrent glioblastomas. Fractional tumor burden maps can
also … An important challenge in the care of patients with high-grade gliomas (HGGs) following …